跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 94 条关于
“MRP1”
全部
94
临床试验
36
药物
25
机构
0
资讯
33
3个月前
NRF2's Dual Role in Ferroptosis: A Context-Dependent Switch for Cancer Therapy
去年
Ferroptosis-Inducing Drug Auranofin Shows Promise in Combination with Chemotherapy for Resistant Neuroblastoma
去年
MRPL Secures US Patent for Pharmaceutical Intermediate Production Technology
去年
Ananda Developments' MRX1 Achieves Key Stability Milestones, Advancing to Phase II Trials
去年
Ananda Pharma Achieves GMP Manufacturing Milestone for MRX1 Pain Treatment Program
去年
Replimune's RP1 Receives FDA Breakthrough Therapy Designation for Advanced Melanoma
2年前
RP1/Nivolumab Combination Shows Durable Responses in Advanced Melanoma
去年
Replimune's RP1 Receives FDA Breakthrough Therapy Designation and BLA Submission for Advanced Melanoma
去年
FDA Reviewing RP1 and Nivolumab Combination for Advanced Melanoma After PD-1 Inhibitor Failure
去年
Ananda Developments Initiates Phase 1 Trial of CBD Compound MRX1 in Australia
第 1 页,共 4 页
上一页
下一页